247 related articles for article (PubMed ID: 14724220)
1. Cyclohexyl-octahydro-pyrrolo[1,2-a]pyrazine-based inhibitors of human N-myristoyltransferase-1.
French KJ; Zhuang Y; Schrecengost RS; Copper JE; Xia Z; Smith CD
J Pharmacol Exp Ther; 2004 Apr; 309(1):340-7. PubMed ID: 14724220
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
[TBL] [Abstract][Full Text] [Related]
3. Selective peptidic and peptidomimetic inhibitors of Candida albicans myristoylCoA: protein N-myristoyltransferase: a new approach to antifungal therapy.
Sikorski JA; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Nagarajan S; Mehta PP; Wade AC; Kishore NS; Bryant ML; Getman DP; McWherter CA; Gordon JI
Biopolymers; 1997; 43(1):43-71. PubMed ID: 9174411
[TBL] [Abstract][Full Text] [Related]
4. [Evolutionary trace analysis of N-myristoyltransferase family].
Sheng CQ; Zhu J; Zhang WN; Xu H; Miao ZY; Yao JZ; Zhang M
Yao Xue Xue Bao; 2007 Feb; 42(2):157-65. PubMed ID: 17518043
[TBL] [Abstract][Full Text] [Related]
5. Effects of L-histidine and its structural analogues on human N-myristoyltransferase activity and importance of EEVEH amino acid sequence for enzyme activity.
Raju RV; Datla RS; Warrington RC; Sharma RK
Biochemistry; 1998 Oct; 37(42):14928-36. PubMed ID: 9778369
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibitor of N-myristoylation: a novel molecular target for cancer.
Shrivastav A; Pasha MK; Selvakumar P; Gowda S; Olson DJ; Ross AR; Dimmock JR; Sharma RK
Cancer Res; 2003 Nov; 63(22):7975-8. PubMed ID: 14633729
[TBL] [Abstract][Full Text] [Related]
7. Immunocytochemical characterization and subcellular localization of human myristoyl-CoA: protein N-myristoyltransferase in HeLa cells.
McIlhinney RA; McGlone K
Exp Cell Res; 1996 Mar; 223(2):348-56. PubMed ID: 8601412
[TBL] [Abstract][Full Text] [Related]
8. Potential role of N-myristoyltransferase in cancer.
Selvakumar P; Lakshmikuttyamma A; Shrivastav A; Das SB; Dimmock JR; Sharma RK
Prog Lipid Res; 2007 Jan; 46(1):1-36. PubMed ID: 16846646
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the discovery of N-myristoyltransferase inhibitors.
Zhao C; Ma S
ChemMedChem; 2014 Nov; 9(11):2425-37. PubMed ID: 25125080
[TBL] [Abstract][Full Text] [Related]
10. Conformationally constrained [p-(omega-aminoalkyl)phenacetyl]-L-seryl-L-lysyl dipeptide amides as potent peptidomimetic inhibitors of Candida albicans and human myristoyl-CoA:protein N-myristoyl transferase.
Nagarajan SR; Devadas B; Zupec ME; Freeman SK; Brown DL; Lu HF; Mehta PP; Kishore NS; McWherter CA; Getman DP; Gordon JI; Sikorski JA
J Med Chem; 1997 May; 40(10):1422-38. PubMed ID: 9154965
[TBL] [Abstract][Full Text] [Related]
11. Myristoyl CoA:protein N-myristoyltransferase: subcellular localization, activation and kinetic behavior in the presence of organic solvents.
Rajala RV; Sharma RK
Biochem Biophys Res Commun; 1995 Mar; 208(2):617-23. PubMed ID: 7695615
[TBL] [Abstract][Full Text] [Related]
12. Differential activation of bovine brain N-myristoyltransferase(s) by a cytosolic activator.
King MJ; Sharma RK
Biochem Biophys Res Commun; 1995 Jul; 212(2):580-8. PubMed ID: 7626073
[TBL] [Abstract][Full Text] [Related]
13. Myristoyl-CoA:protein N-myristoyltransferase: a novel molecular approach for cancer therapy (Review).
Selvakumar P; Pasha MK; Ashakumary L; Dimmock JR; Sharma RK
Int J Mol Med; 2002 Oct; 10(4):493-500. PubMed ID: 12239600
[TBL] [Abstract][Full Text] [Related]
14. Regulation of N-myristoyltransferase by novel inhibitor proteins.
Shrivastav A; Selvakumar P; Bajaj G; Lu Y; Dimmock JR; Sharma RK
Cell Biochem Biophys; 2005; 43(1):189-202. PubMed ID: 16043893
[TBL] [Abstract][Full Text] [Related]
15. N-myristoylation of Arf proteins in Candida albicans: an in vivo assay for evaluating antifungal inhibitors of myristoyl-CoA: protein N-myristoyltransferase.
Lodge JK; Jackson-Machelski E; Devadas B; Zupec ME; Getman DP; Kishore N; Freeman SK; McWherter CA; Sikorski JA; Gordon JI
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():357-366. PubMed ID: 9043113
[TBL] [Abstract][Full Text] [Related]
16. Myristoyl-CoA:protein N-myristoyltransferases: isoform identification and gene expression in retina.
Rundle DR; Rajala RV; Alvarez RA; Anderson RE
Mol Vis; 2004 Mar; 10():177-85. PubMed ID: 15041955
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyltransferase inhibitors.
Sheng C; Xu H; Wang W; Cao Y; Dong G; Wang S; Che X; Ji H; Miao Z; Yao J; Zhang W
Eur J Med Chem; 2010 Sep; 45(9):3531-40. PubMed ID: 20615585
[TBL] [Abstract][Full Text] [Related]
18. Protein N-myristoylation in Escherichia coli: reconstitution of a eukaryotic protein modification in bacteria.
Duronio RJ; Jackson-Machelski E; Heuckeroth RO; Olins PO; Devine CS; Yonemoto W; Slice LW; Taylor SS; Gordon JI
Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1506-10. PubMed ID: 2406721
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and discovery of pyrazine-pyridine biheteroaryl as a novel series of potent vascular endothelial growth factor receptor-2 inhibitors.
Kuo GH; Wang A; Emanuel S; Deangelis A; Zhang R; Connolly PJ; Murray WV; Gruninger RH; Sechler J; Fuentes-Pesquera A; Johnson D; Middleton SA; Jolliffe L; Chen X
J Med Chem; 2005 Mar; 48(6):1886-900. PubMed ID: 15771433
[TBL] [Abstract][Full Text] [Related]
20. Myristoyltransferase and calcineurin: novel molecular therapeutic target for epilepsy.
Lakshmikuttyamma A; Selvakumar P; Tuchek J; Sharma RK
Prog Neurobiol; 2008 Jan; 84(1):77-84. PubMed ID: 17997006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]